Clinical Trial Update: Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining same-day restart of the B/F/TAF HIV regimen after NNRTI discontinuation in HIV-infected patients; the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: National Center for AIDS/STD Control and Prevention, China CDC | Conditions: HIV Infection, HIV | Phase 4 | Status: NOT_YET_RECRUITING